Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,296,663
  • Shares Outstanding, K 50,224
  • Annual Sales, $ 1,309 M
  • Annual Income, $ 117,560 K
  • EBIT $ 207 M
  • EBITDA $ 311 M
  • 60-Month Beta 0.32
  • Price/Sales 3.28
  • Price/Cash Flow 14.11
  • Price/Book 4.97

Options Overview Details

View History
  • Implied Volatility 30.75% ( -1.66%)
  • Historical Volatility 42.01%
  • IV Percentile 23%
  • IV Rank 18.85%
  • IV High 57.61% on 11/06/24
  • IV Low 24.51% on 08/26/24
  • Put/Call Vol Ratio 0.63
  • Today's Volume 13
  • Volume Avg (30-Day) 975
  • Put/Call OI Ratio 1.25
  • Today's Open Interest 15,350
  • Open Int (30-Day) 19,678

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.20
  • Number of Estimates 5
  • High Estimate 1.22
  • Low Estimate 1.18
  • Prior Year 1.04
  • Growth Rate Est. (year over year) +15.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
70.25 +21.78%
on 10/31/24
94.99 -9.93%
on 11/12/24
+11.08 (+14.88%)
since 10/22/24
3-Month
70.25 +21.78%
on 10/31/24
94.99 -9.93%
on 11/12/24
+10.05 (+13.31%)
since 08/22/24
52-Week
70.25 +21.78%
on 10/31/24
97.97 -12.68%
on 05/15/24
+3.57 (+4.35%)
since 11/22/23

Most Recent Stories

More News
Haemonetics: Fiscal Q2 Earnings Snapshot

Haemonetics: Fiscal Q2 Earnings Snapshot

HAE : 85.55 (+0.14%)
Haemonetics: Fiscal Q1 Earnings Snapshot

Haemonetics: Fiscal Q1 Earnings Snapshot

HAE : 85.55 (+0.14%)
Haemonetics: Fiscal Q4 Earnings Snapshot

Haemonetics: Fiscal Q4 Earnings Snapshot

HAE : 85.55 (+0.14%)
Haemonetics: Fiscal Q3 Earnings Snapshot

Haemonetics: Fiscal Q3 Earnings Snapshot

HAE : 85.55 (+0.14%)
HAEMONETICS COMPLETES ACQUISITION OF OPSENS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 85.55 (+0.14%)
OPS.TO : 2.90 (unch)
Stocks in play: OpSens Inc.

Announces that the Superior Court of Québec issued a final order today in connection with the previously ...

HAE : 85.55 (+0.14%)
OPS.TO : 2.90 (unch)
OPSENS RECEIVES FINAL ORDER FOR ARRANGEMENT WITH HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 85.55 (+0.14%)
OPS.TO : 2.90 (unch)
OPSENS' SHAREHOLDERS APPROVE ARRANGEMENT WITH HAEMONETICS

/CNW/ - OpSens Inc. ("OpSens" or the "Corporation") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions...

OPSSF : 2.1389 (+0.64%)
HAE : 85.55 (+0.14%)
OPS.TO : 2.90 (unch)
OPSENS OBTAINS REGULATORY CLEARANCE OF ARRANGEMENT IN THE UNITED STATES AND CANADA; REGULATORY APPROVALS CONDITION SATISFIED

All amounts in this press release are in Canadian dollars. Clearance under both the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the...

OPSSF : 2.1389 (+0.64%)
HAE : 85.55 (+0.14%)
OPS.TO : 2.90 (unch)
INDEPENDENT PROXY ADVISORY FIRM ISS RECOMMENDS SHAREHOLDERS VOTE "FOR" OPSENS INC. PLAN OF ARRANGEMENT WITH HAEMONETICS CORPORATION

All amounts in this press release are in Canadian dollars. Leading independent proxy advisor says cash offer provides meaningful 50.3% premium to OpSens Inc.'s...

OPSSF : 2.1389 (+0.64%)
HAE : 85.55 (+0.14%)
OPS.TO : 2.90 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood...

See More

Key Turning Points

3rd Resistance Point 87.70
2nd Resistance Point 86.85
1st Resistance Point 86.20
Last Price 85.55
1st Support Level 84.70
2nd Support Level 83.85
3rd Support Level 83.20

See More

52-Week High 97.97
Fibonacci 61.8% 87.38
Last Price 85.55
Fibonacci 50% 84.11
Fibonacci 38.2% 80.84
52-Week Low 70.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar